Verified
You know Ian Haydon from many appearances on CNN and other networks celebrating his heroic act of volunteering to test Moderna’s experimental Covid vaccine. The sun has now set on Haydon’s television
career. He is no longer useful to the Pharmedia narratives that all vaccines are always safe for all people,
that Moderna’s business partners,Tony Fauci and Bill Gates were justified in skipping animal studies, and
that Moderna’s vaccine will soon rescue us from the Pandemic.
Ian Haydon is now an embarrassment to Fauci & Gates and their CNN cheerleaders. He will therefore vanish
into the censorship twilight.
Moderna chose Haydon for the study because of his robust good health. He was among the 15 volunteers in
the high-dose group. Within 45 days ,three of these—a shocking 20%—experienced “serious” adverse events,
according to Moderna’s press release, meaning they required hospitalization or medical intervention.
Less than 12 hours after vaccination, Hayden suffered muscle aches, vomiting, spiked a 103.2* fever and lost
consciousness. His girlfriend caught him as he fell. His Moderna trial supervisor instructed Haydon to call 911
and described him as being the “sickest in his life”. Moderna let Haydon believe the illness was just a sad
coincidence unrelated to the jab. Moderna never told Haydon he was suffering an Adverse Event.
“Moderna’s press release was the first I learned of the 3 AEs in the high dose group.”Haydon confessed today
on Twitter, ”Later a study doc confirmed that what happened to me was an AE.” While hiding this truth, Moderna
encouraged Haydon to appear on TV to deceive the public, and its shareholders, by declaring Moderna’s COVID
vaccine trials a smashing success.
On May 7 Haydon told Sanjay Gupta about his reactions in a pre-interview. The two men agreed to keep this
bad news secret when he went on air. This corrupt deal bespeaks the pathetic state of journalism at CNN.
Fauci and Gates are proceeding with their plan to funnel half a billion taxpayer dollars into their reckless
vanity project to create 30 million doses by November and 2 billion within a year manufactured in the US
and Switzerland.